Participants are requested to send
us the following information:
1) Your name, title and
organization/university you represent, if any
2) A brief write-up on the methodology
followed;
including descriptors generated, the final set of descriptors used to
build the model, steps carried out
for model building, the algorithm used
for model
building, any metrics generated as part of model building and the tools
/software used for these various steps.
3) A text file containing the predictions
for the
test set compounds along with identifier; Optionally, you may also send
an sdf of the test set compounds
along with the prediction.
Please send the required data and information to editor@qsarworld.com. The
last date for submission of entries is 31st January
2009.
If a simple regression model does not yield good results, a nested
approach can be tried. Read a primer on Nested Regression
model here >> Read
To
know about how Sarchitect Designer builds nested models, read the
manual after downloading the tool.
1. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P.
J.Experimental and computational approaches to estimate solubility and
permeability in drug discovery
and development settings. Adv. Drug Del. Rev.1997, 23, 3–25.
2. Larsen, T.; Link, A. A timely reassessment of early prediction in the bioavailability of orally administered drugs. Angew. Chem. Int. Ed. Engl. 2005, 44, 4432-4.
3. Yoshida, F.; Topliss, J. G. QSAR model for drug human oral bioavailability. J. Med. Chem.2000, 43, 2575-85.
Erratum in: J. Med. Chem.2000, 43, 4723.
4. Bains, W.; Gilbert, R.; Sviridenko, L.; Gascon, J. M.;
Scoffin, R.; Birchall, K.; Harvey, I.; Caldwell, J. Evolutionary
computational methods to predict
oral bioavailability QSPRs. Curr. Opin. Drug Disc. Dev.2002,5, 44–5.
5. Pintore, M.; Van de Waterbeemd, H.; Piclin, N.;
Chrétien, J. R.Prediction of oral bioavailability by adaptive
fuzzy partitioning. Eur. J. Med. Chem.2003,38, 427-431.
6. Andrews, C. W.; Bennett.,L.; Yu, L. X. Predicting human
oral bioavailability of a compound: development of a novel quantitative
structure-bioavailability
relationship. Pharm. Res.2000, 17, 639-44.
